Morgan Stanley shares technical analysis: Support test at $204.64 limits further decline

Morgan Stanley shares technical analysis: Support test at $204.64 limits further decline
Morgan Stanley drops 3.03% to $207.74

Morgan Stanley (MS) stock is trading at $207.74, down 3.03% for the day and opening with a gap lower amid heightened volatility. The price remains below its key moving averages on short and medium timeframes, while still holding above longer-term averages.

MS price prediction
24H -0.22%
$183.89
48H -0.64%
$183.12
7D -0.82%
$182.78
1M -1.69%
$181.18
3M 9.32%
$201.47
6M -0.14%
$184.04
12M 13%
$208.26
Current price: $184.3 -5.7300 3.02%
Closed 10/30
Daily range 182.19 Arrow from to Icon 186.99
Weekly range 181.01 Arrow from to Icon 192.90
Loading...

Highlights

  • Morgan Stanley stock has increased its dividend four times in five years, achieving 22.85% average annual growth.
  • Bank of Montreal registered medium-term notes partially linked to Morgan Stanley stock, signaling potential demand from structured products.
  • Morgan Stanley stock trades below short- and medium-term averages with bearish momentum, and the expected price range for the next 2 to 3 days is $204.64 to $210.84.

Shareholder returns rise as capital returns fail to offset selling

Morgan Stanley has steadily increased its dividend four times on a year-over-year basis in the past five years, achieving an average annual growth of 22.85%, according to Finance Yahoo. This ongoing pattern demonstrates a track record of returning capital to shareholders and reflects sustained underlying profitability, but has not prevented current downward pressure on the stock. In addition, Streetinsider reported that Bank of Montreal filed a registration statement for medium-term notes due August 31, 2029, which are partially linked to Morgan Stanley's common stock and could introduce additional structured product demand.

Morgan Stanley asset chart
Morgan Stanley price dynamics. Source: TradingView.

Downtrend persists as negative momentum and support levels converge

On the technical side, MS is trading below both the MA-20 and MA-50 on the hourly chart, with the nearest support level seen at $204.64 and immediate resistance at the Ichimoku Kijun set at $214.47. The long-term MA-200 is currently providing a buffer below the market. Momentum indicators are heavily negative: both MACD and ADX confirm active Sell signals, while Bull/Bear Power reflects dominant intraday seller pressure and the Awesome Oscillator also confirms the downtrend. RSI, Stoch RSI, and CCI are all in oversold territory, suggesting that downside is stretched, but no reversal signals have been confirmed.

Bearish continuation likely as consolidation limits recovery prospects

Looking ahead to the next two to three trading days, price action is expected to consolidate within a volatility band between $204.64 and $210.84. There is a much higher probability (78%) of a continued downward move, while the likelihood of an upward move remains low (22%). Should MS break above immediate resistance at $214.47, a recovery scenario could play out; conversely, a drop below $204.64 would likely extend recent losses.

Anton Kharitonov, expert at Traders Union, sees Morgan Stanley under continued technical and sentiment pressure despite a strong dividend track record. He notes the persistent sell signals and a lack of reversal signals, with the stock holding a negative bias below critical averages. Near-term movement is likely to stay capped by $210.84, with the downside at risk if $204.64 yields. "Until price reclaims $214.47 and signals a shift in momentum, I stay defensive and see no reason to chase the upside here."

Earlier, analysts noted that Morgan Stanley's stock was in a consolidation phase with risks skewed toward further downside if key support levels were breached. The latest technical signals and heightened volatility now reinforce the bearish scenario, making a decisive move below $204.64 a critical risk for further declines in the near term.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.